These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Specialists should decide if oral contraceptives are suitable in cases of predisposition to thrombosis]. Strandberg K; Victor A Lakartidningen; 1996 Jan; 93(3):118. PubMed ID: 8569316 [No Abstract] [Full Text] [Related]
25. [Inferior caval thrombosis and pulmonary thromboembolism as complications due to the use of oral hormonal contraceptives]. Koroleva IM; Dolgushina LM Vestn Rentgenol Radiol; 2004; (4):47-9. PubMed ID: 15626235 [No Abstract] [Full Text] [Related]
26. Prescribing oral contraceptives. Focusing on each woman as an individual case. Tufts KA; Chung C AWHONN Lifelines; 2003; 7(4):332-8. PubMed ID: 14528590 [No Abstract] [Full Text] [Related]
28. [Significance of pharmacoepidemiology for drug monitoring and quality of care: the pill]. Stricker BH; Rosendaal FR Ned Tijdschr Geneeskd; 1995 Dec; 139(49):2541-3. PubMed ID: 8657314 [No Abstract] [Full Text] [Related]
30. A clinical dilemma. Divinsky M Can Fam Physician; 1996 Mar; 42():406. PubMed ID: 8616279 [No Abstract] [Full Text] [Related]
31. Should coagulation tests be used to determine which oral contraceptive users have an increased risk of thrombophlebitis? Comp PC Contraception; 2006 Jan; 73(1):4-5. PubMed ID: 16371288 [No Abstract] [Full Text] [Related]